Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Accumulated Expenses (2016 - 2025)

Argan's Accumulated Expenses history spans 15 years, with the latest figure at $28.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 21.2% year-over-year to $28.0 million; the TTM value through Oct 2025 reached $28.0 million, up 21.2%, while the annual FY2025 figure was $29.8 million, 63.57% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $28.0 million at Argan, down from $71.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $81.7 million in Q1 2024 and bottomed at $13.1 million in Q3 2023.
  • The 5-year median for Accumulated Expenses is $39.6 million (2022), against an average of $37.3 million.
  • The largest annual shift saw Accumulated Expenses surged 346.9% in 2024 before it tumbled 73.11% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $42.7 million in 2021, then dropped by 5.69% to $40.2 million in 2022, then tumbled by 55.47% to $17.9 million in 2023, then grew by 29.12% to $23.1 million in 2024, then rose by 21.2% to $28.0 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's Accumulated Expenses are $28.0 million (Q4 2025), $71.5 million (Q3 2025), and $16.3 million (Q2 2025).